Aspira Pathlab & Diagnostics (BOM:540788) Payments of Debt: ₹0.0 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:540788 Aspira Pathlab & Diagnostics Ltd BOM:540788
51 GF Score
Price ₹97.00
GF Value ₹74.29
Valuation Significantly Overvalued
View Full Analysis

What is Aspira Pathlab & Diagnostics Payments of Debt?

Aspira Pathlab & Diagnostics BOM:540788 51 Payments of Debt is ₹0.0 Mil as of Jun. 2026. GuruFocus rates BOM:540788 with a GF Score™ of 51/100 and a GF Value™ of ₹74.29 (Significantly Overvalued).

Aspira Pathlab & Diagnostics's Payments of Debt for the three months ended in Jun. 2026 was ₹0.0 Mil.

Aspira Pathlab & Diagnostics's Payments of Debt for the trailing twelve months (TTM) ended in Jun. 2026 was ₹0.0 Mil.

Aspira Pathlab & Diagnostics Payments of Debt Related Terms

Aspira Pathlab & Diagnostics Payments of Debt Historical Data

* Premium members only.

The historical data trend for Aspira Pathlab & Diagnostics's Payments of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aspira Pathlab & Diagnostics Payments of Debt Chart

Aspira Pathlab & Diagnostics Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Payments of Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only -4.84 0.00 0.00 0.00 0.00

Aspira Pathlab & Diagnostics Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Payments of Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
BOM:540788
51GF Score
Aspira Pathlab & Diagnostics Ltd BOM:540788
Payments of Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Aspira Pathlab & Diagnostics Payments of Debt Calculation

Payments of Debt represents all the cash outflow from debt, including both long-term debt and short-term debt.

Payments of Debt for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Payments of Debt →
What does a Payments of Debt of ₹0.0 Mil mean?
Aspira Pathlab & Diagnostics (BOM:540788) has a Payments of Debt of ₹0.0 Mil as of Jun. 2026. Payments of Debt is all the cash outflow from debt, including both long-term debt and short-term debt. View historical data on Aspira Pathlab & Diagnostics and its competitors.
Is Aspira Pathlab & Diagnostics' Payments of Debt too high?
Aspira Pathlab & Diagnostics' current Payments of Debt is ₹0.0 Mil. Overall, Aspira Pathlab & Diagnostics has a GF Score™ of 51/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Aspira Pathlab & Diagnostics' Payments of Debt compare to TMO and DHR?
Aspira Pathlab & Diagnostics' Payments of Debt of ₹0.0 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Payments of Debt for a Medical Diagnostics & Research company?
A good Payments of Debt depends on the Medical Diagnostics & Research industry context. However, Payments of Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Payments of Debt mean?
A high Payments of Debt can signal that a stock is expensive relative to its fundamentals. Payments of Debt is all the cash outflow from debt, including both long-term debt and short-term debt. View historical data on Aspira Pathlab & Diagnostics and its competitors. Aspira Pathlab & Diagnostics's current Payments of Debt is ₹0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aspira Pathlab & Diagnostics stock overvalued right now?
Based on GuruFocus' analysis, Aspira Pathlab & Diagnostics (BOM:540788) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹74.29, compared to a current price of ₹97.00 — trading 30.6% above its estimated fair value. The current Payments of Debt is ₹0.0 Mil. Aspira Pathlab & Diagnostics' overall GF Score™ is 51/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Payments of Debt calculated?
Payments of Debt is calculated from a company's financial statements. For Aspira Pathlab & Diagnostics (BOM:540788), the current Payments of Debt is ₹0.0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Aspira Pathlab & Diagnostics (BOM:540788) Overvalued in 2026?

Based on GuruFocus' analysis, Aspira Pathlab & Diagnostics stock appears to be overvalued. The current stock price of ₹97.00 is trading 30.6% above its estimated GF Value™ of ₹74.29. GuruFocus considers Aspira Pathlab & Diagnostics to be Significantly Overvalued.

Key valuation signals for BOM:540788:

  • Payments of Debt: ₹0.0 Mil
  • GF Value™: ₹74.29 vs. price of ₹97.00 (30.6% above fair value)
  • GF Score™: 51/100

No single metric tells the full story. See the BOM:540788 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Aspira Pathlab & Diagnostics Business Description

Address 6 & 7, Bhaveshwar Arcade, Near Shreyas Junction LBS Marg, Behind Saraswat Bank, Ghatkopar (west), Mumbai, MH, IND, 400086
Aspira Pathlab & Diagnostics Ltd is mainly engaged in pathology and related healthcare services. It operates laboratories that conduct a wide range of pathological investigations across branches such as biochemistry, hematology, histopathology, microbiology, immunochemistry, immunology, virology, cytology, and other pathological and radiological tests. The services offered include pathology tests, sonography, X-rays, and radiology. The company also provides various health packages like gynecology profiles, anemia profiles, monsoon profiles, coagulation tests, cancer screening packages, newborn screening and IEM panels, orthopedic profiles, allergy panels, and cardiac profiles. These comprehensive diagnostic services assist in disease diagnosis.
51GF Score

Get the complete analysis for BOM:540788

Payments of Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹97.00
Price
₹74.29
GF Value